Savior siblings and Fanconi anemia: Analysis of success rates from the family's perspective

Genetics in Medicine

Volumn 17, Issue 11, 2015, Pages 935-938

  Trujillo, Juan P ^a,b   Surralles, Jordi ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Aneuploidy; embryo selection; Fanconi anemia; preimplantation genetic diagnosis; savior siblings

Indexed keywords

HLA ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EMBRYO TRANSFER; EMBRYOLOGY; FAMILY ATTITUDE; FANCONI ANEMIA; FEMALE; FERTILIZATION IN VITRO; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MATERNAL AGE; OOCYTE; POLYMERASE CHAIN REACTION; PREGNANCY; SIBLING; ALLOTRANSPLANTATION; ANEUPLOIDY; DONOR; GENETIC SCREENING; GENETICS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; IN VITRO FERTILIZATION; MALE; PREGNANCY OUTCOME; PREIMPLANTATION GENETIC DIAGNOSIS; PROCEDURES; TREATMENT OUTCOME;

ADULT; ANEUPLOIDY; FANCONI ANEMIA; FEMALE; FERTILIZATION IN VITRO; GENETIC TESTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; PREGNANCY; PREGNANCY OUTCOME; PREIMPLANTATION DIAGNOSIS; SIBLINGS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84938823412     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.206     Document Type: Article

References (12)

1. Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001;285:3130-3133.
2. Grewal SS, Kahn JP, MacMillan ML, Ramsay NK, Wagner JE. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 2004;103:1147-1151.
3. Samuel GN, Strong KA, Kerridge I, Jordens CF, Ankeny RA, Shaw PJ. Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do "saviour siblings" have in paediatric transplantation Arch Dis Child 2009;94:317-320.
4. Bogliolo M, Schuster B, Stoepker C, et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet 2013;92:800-806.
5. Castella M, Pujol R, Callén E, et al. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood 2011;117:3759-3769.
6. Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014;101:656-663.e1.
7. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003;101:1249-1256.
8. Peffault de Latour R, Porcher R, Dalle JH, et al.; FA Committee of the Severe Aplastic Anemia Working Party; Pediatric Working Party of the European Group for Blood and Marrow Transplantation. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood 2013;122:4279-4286.
9. Tolar J, Becker PS, Clapp DW, et al. Gene therapy for Fanconi anemia: one step closer to the clinic. Hum Gene Ther 2012;23:141-144.
10. Raya A, Rodríguez-Pizà I, Guenechea G, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009;460:53-59.
11. Liu GH, Suzuki K, Li M, et al. Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun 2014;5:4330.
12. Rio P, Banõs R, Lombardo A, et al. Targeted gene therapy and cell reprogramming in Fanconi anemia. EMBO Mol Med 2014;6: 835-848.